Kurma Partners
Overview
Kurma Partners is a key European venture capital group specializing in healthcare, managing €470 million in assets . The firm operates through two dedicated franchises: Kurma Biofund, which focuses on therapeutics, and Kurma Diagnostics, which focuses on diagnostic and digital health . Kurma invests in companies from their inception and to finance their growth, across the spectrum of the healthcare sector through its various franchises . They transform scientific discoveries into medicines and medical devices .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tacalyx | Apr 2026 | Seed | Co-investor |
| Laigo Bio | Mar 2026 | Seed | Lead |
| Alveus Therapeutics | Feb 2026 | Series A Extension | Co-investor |
| Shorla Oncology | Jan 2026 | Series C | Lead |
| Alveus Therapeutics | Jan 2026 | Series A | Co-investor |
Key People
Thierry Laugel
Managing Partner
Arnaud Pradier
Venture Partner
Dominique Poiroux
Venture Partner
Amanda Gett-Chaperot
Partner
Benjamin Belot
Partner - Investing In Healthtech, AI TechBio
Daniel Parera
Partner
Hadrien Bouchez
Partner
Jean-Francois Rivassou
Partner
Philippe Peltier
Partner
Sylvain Cascarino
CFO - Partner
Séverine PENOT
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
